Regression From Early GDM to Normal Glucose Tolerance and Adverse Pregnancy Outcomes in the Treatment of Booking Gestational Diabetes Mellitus Study
医学
妊娠期糖尿病
糖尿病
怀孕
产科
妊娠期
糖耐量试验
内分泌学
胰岛素抵抗
遗传学
生物
作者
David Simmons,Jincy Immanuel,William M. Hague,Helena Teede,Christopher J. Nolan,Michael J. Peek,Jeff R. Flack,Mark McLean,Vincent Wong,Emily Hibbert,Alexandra Kautzky‐Willer,Jürgen Harreiter,Helena Backman,Emily Gianatti,Arianne Sweeting,Viswanathan Mohan,N. Wah Cheung,David Simmons,N. Wah Cheung,Jincy Immanuel
出处
期刊:Diabetes Care [American Diabetes Association] 日期:2024-03-29卷期号:47 (12): 2079-2084被引量:8
OBJECTIVE To compare pregnancy outcomes among women with a normal oral glucose tolerance test (OGTT) before 20 weeks’ gestation (early) and at 24–28 weeks’ gestation (late) (no gestational diabetes mellitus, or No-GDM), those with early GDM randomized to observation with a subsequent normal OGTT (GDM-Regression), and those with GDM on both occasions (GDM-Maintained). RESEARCH DESIGN AND METHODS Women at <20 weeks’ gestation with GDM risk factors who were recruited for a randomized controlled early GDM treatment trial were included. Women with treated early GDM and late GDM (according to the World Health Organization’s 2013 criteria) were excluded from this analysis. Logistic regression compared pregnancy outcomes. RESULTS GDM-Regression (n = 121) group risk factor profiles and OGTT results generally fell between the No-GDM (n = 2,218) and GDM-Maintained (n = 254) groups, with adjusted incidences of pregnancy complications similar between the GDM-Regression and No-GDM groups. CONCLUSIONS Women with early GDM but normal OGTT at 24–28 weeks’ gestation had pregnancy outcomes that were similar to those of individuals without GDM. Identifying early GDM likely to regress would allow treatment to be avoided.